M 173
Pill imprint M 173 has been identified as Metolazone 5 mg.
Metolazone is used in the treatment of edema; high blood pressure and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy.
Metolazone 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Metolazone Images
- Imprint:
-
M
173 - Strength:
- 5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6173
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0024 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Metolazone resources
- Metolazone (Wolters Kluwer)
- metolazone (Cerner Multum)
- metolazone (Micromedex) - Includes Dosage Information
- Metolazone (AHFS DI)
- Metolazone (FDA)
- Metolazone (Wolters Kluwer)
Search Again
